Characteristics, Mortality, and Clinical Outcomes of Hospitalized Patients with COVID-19 and Diabetes: A Reference Single-Center Cohort Study from Poland
Table 1
Comparison of basic characteristics and clinical outcomes of DP and nondiabetic patients.
Characteristics
All
Diabetes
Nondiabetics
value
OR (CI 95% adjusted for age and gender)
value
Number
5191
1364
3827
Age (years)
64 (51–74)
70 (62–77)
62 (47–72)
<0.001
NA
NA
Age class >65 years (N (%))
2409 (46.4%)
869 (63.7%)
1540 (40.3%)
<0.001
NA
NA
Female (n (%))
2348 (45.2%)
606 (44.4%)
1742 (45.5%)
0.506
NA
NA
BMI (kg/m2)
28.3 (25.2–32.1)
30.0 (26.4–34.6)
27.8 (24.7–31.4)
<0.001
NA
NA
CVD (n (%))
3304 (63.6%)
1195 (87.6%)
2109 (55.1%)
<0.001
NA
NA
Endpoints
In-hospital death (yes (%))
957 (18.4%)
358 (26.2%)
599 (15.7%)
<0.001
1.22 (1.04–1.43)
0.016
Mechanical ventilation (yes (%))
643 (12.4%)
211 (15.5%)
432 (11.3%)
<0.001
1.33 (1.11–1.60)
0.002
Admission to an ICU (n (%))
634 (12.2%)
214 (15.7%)
420 (11%)
<0.001
1.44 (1.20–1.73)
<0.001
Length of hospital stay (days: median (IQR))
14 (9–21)
15 (10–24)
13 (9–20)
<0.001
1.01 (0.996–1.019)
0.226
Data are presented as median (Q1–Q3) or N (%); BMI, body mass index; CVD, cardiovascular disease: ischemic heart disease including the history of myocardial infarction, and cerebrovascular disease including the history of stroke, heart failure, arterial hypertension, atrial fibrillation; ICU, intensive care unit. Data available, N = 2403.
